CD4 T Cell Immune Response Modulates Blood-Brain Barrier Permeability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack effective solutions for treating and preventing infections of the central nervous system, particularly in modulating the blood-brain barrier permeability to allow therapeutic agents to reach the brain, which is crucial for managing viral, bacterial, and other pathogenic infections, as well as cancer.
Innovation Solution
A method involving the administration of an immunogenic agent to induce a CD4 T cell immune response, thereby increasing blood-brain barrier permeability, combined with therapeutic agents such as immune checkpoint protein inhibitors or antibodies to treat or prevent infections and cancers in the brain and spinal cord.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If the blood-brain barrier is maintained intact to protect the brain, then brain protection is improved, but therapeutic agent delivery is worsened
Solution Approach 1:
The patent applies preliminary action by administering an immunogenic agent (such as a virus-like particle or vaccine) before the actual therapeutic need arises. This preliminary immunization triggers the formation of memory T cells that will later facilitate therapeutic agent delivery when needed, without compromising the protective function of the blood-brain barrier during normal conditions
Solution Approach 2:
The patent uses memory T cells as an intermediary mechanism. These immune cells act as mediators that temporarily modulate blood-brain barrier permeability in response to specific triggers, allowing therapeutic agents to pass through without permanently compromising the barrier's protective function. The T cells facilitate controlled, transient opening of the barrier only when therapeutic delivery is required
2Speed
If high dose intranasal VSV delivery is used to reach the brain, then viral dissemination to the brain is improved, but blood-brain barrier integrity is worsened
Solution Approach 1:
The patent employs a disposable, transient mechanism for blood-brain barrier modulation. Rather than permanently altering barrier integrity, the immunogenic agent triggers a temporary, controlled response where memory T cells facilitate brief, localized permeability changes sufficient for therapeutic delivery, then return to baseline protective function
Solution Approach 2:
The patent applies parameter changes by temporarily altering the permeability parameter of the blood-brain barrier only when and where needed for therapeutic delivery. The immunogenic agent and subsequent memory T cell response modulate barrier properties dynamically, changing permeability from low (protective state) to temporarily higher (delivery state) and back, without permanent structural damage
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for the effective treatment and prevention of central nervous system infections and cancers by enhancing antibody access and immune response, facilitating the delivery of therapeutic agents across the blood-brain barrier.
Implementation Method 1
administering an immunogenic agent to induce an immune response, thereby inducing permeability of the blood brain barrier (BBB) in the subject
Data Source
AI summary
The present disclosure relates to compositions and methods for treating or preventing a disease or disorder of the brain, spinal cord or central nervous system. It is described herein that an immunogenic composition which induces a CD4 T cell immune response induces permeability of the blood brain barrier, and allows for the access of a therapeutic antibody or agent to the brain, spinal cord or central nervous system.